# Topical Itraconazole in the Treatment of Basal Cell Carcinoma

> **NCT02120677** · EARLY_PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 5 (actual)

## Conditions studied

- Basal Cell Carcinoma

## Interventions

- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT02120677
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2019-01-30
- **Final completion:** 2019-01-30
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120677, "Topical Itraconazole in the Treatment of Basal Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02120677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*